États-Unis · Plateformes & données · MarketBeat

What OptimizeRx (OPRX) Said on Its Q3 Earnings Call

Publié par MarketBeat · États-Unis il y a 1 h

Image from MarketBeat Media, LLC. · MarketBeat

Résumé détaillé

OptimizeRx (NASDAQ:OPRX) lowered its 2026 revenue outlook after third-quarter sales fell 17%, even as cost reductions and a favorable product mix helped the healthcare marketing technology company increase profitability. The company now expects full-year revenue of $87 million to $93 million, while

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

What OptimizeRx (OPRX) Said on Its Q3 Earnings Call

Résumé détaillé

À lire aussi

These 5 Dividend Aristocrats® Have Raised Payouts for Decades

Nasdaq futures fall as Nvidia sinks 8% after hours on report board may oust Huang

Samsung Fire & Marine Q3 profit falls on weaker investment income; shares down

Here are the major earnings before the open Thursday

Prediction markets tied to clinical trials and drug approvals draw lawmakers' ire

CoreWeave Reportedly Plans $4B Investment-Grade Loan After Strong Earnings Beat — But Shares Fall After-Hours On Nvidia CEO Drama

What OptimizeRx (OPRX) Said on Its Q3 Earnings Call

Résumé détaillé

Partager

À lire aussi

These 5 Dividend Aristocrats® Have Raised Payouts for Decades

Nasdaq futures fall as Nvidia sinks 8% after hours on report board may oust Huang

Samsung Fire & Marine Q3 profit falls on weaker investment income; shares down

Here are the major earnings before the open Thursday

Prediction markets tied to clinical trials and drug approvals draw lawmakers' ire

CoreWeave Reportedly Plans $4B Investment-Grade Loan After Strong Earnings Beat — But Shares Fall After-Hours On Nvidia CEO Drama